Omnicell, Inc. - Common Stock (OMCL)

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 6.3%. This performance is a noticeable divergence from the S&P 500’s 5.1% return.

Healthcare services company Astrana Health will be reporting results tomorrow afternoon. Here’s what investors should know.

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect.

Healthcare technology company Waystar Holding (NASDAQ:WAY) will be reporting results tomorrow morning. Here’s what to look for.

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 2.8% above analysts’ consensus estimates.

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect.

Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).

The company makes software the manages medication dispensing.

Stocks are paring this morning's gains that followed Meta Platforms' upbeat quarterly results.

The Russell 2000 is trailing the Nasdaq Composite and S&P500, yet there are still plenty of Russel stocks worth looking into.